| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hirofumi Hirakawa, Takeshi Terao, Toshiko Tanaka, Hiroaki Sato, Reiji Yoshimur. A Case of Mutism in Noncatatonic Schizophrenia Responding to Small Dose of Fluvoxamine Addition to Clozapine. Journal of clinical psychopharmacology. vol 36. issue 5. 2017-04-28. PMID:27508430. |
a case of mutism in noncatatonic schizophrenia responding to small dose of fluvoxamine addition to clozapine. |
2017-04-28 |
2023-08-13 |
Not clear |
| Rebecca N S Harrison, Robin M Murray, Sang Hyuck Lee, Jose Paya Cano, David Dempster, Charles J Curtis, Danai Dima, Fiona Gaughran, Gerome Breen, Simone de Jon. Gene-expression analysis of clozapine treatment in whole blood of patients with psychosis. Psychiatric genetics. vol 26. issue 5. 2017-04-25. PMID:27315048. |
clozapine is an atypical antipsychotic primarily prescribed for treatment-resistant schizophrenia. |
2017-04-25 |
2023-08-13 |
Not clear |
| Charilaos Gerasimou, Georgia Phaedra Vitali, George D Vavougios, Charalabos Papageorgiou, Athanasios Douzenis, Styliani I Kokoris, Ioannis Liappas, Emmanouil Rizo. Clozapine Associated with Autoimmune Reaction, Fever and Low Level Cardiotoxicity - A Case Report. In vivo (Athens, Greece). vol 31. issue 1. 2017-04-25. PMID:28064233. |
clozapine is a second-generation antipsychotic drug used in treatment-resistant schizophrenia. |
2017-04-25 |
2023-08-13 |
Not clear |
| Makoto Kinoshita, Shusuke Numata, Atsushi Tajima, Hidenaga Yamamori, Yuka Yasuda, Michiko Fujimoto, Shinya Watanabe, Hidehiro Umehara, Shinji Shimodera, Takanobu Nakazawa, Masataka Kikuchi, Akihiro Nakaya, Hitoshi Hashimoto, Issei Imoto, Ryota Hashimoto, Tetsuro Ohmor. Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia. International journal of molecular sciences. vol 18. issue 3. 2017-04-20. PMID:28335437. |
effect of clozapine on dna methylation in peripheral leukocytes from patients with treatment-resistant schizophrenia. |
2017-04-20 |
2023-08-13 |
Not clear |
| Makoto Kinoshita, Shusuke Numata, Atsushi Tajima, Hidenaga Yamamori, Yuka Yasuda, Michiko Fujimoto, Shinya Watanabe, Hidehiro Umehara, Shinji Shimodera, Takanobu Nakazawa, Masataka Kikuchi, Akihiro Nakaya, Hitoshi Hashimoto, Issei Imoto, Ryota Hashimoto, Tetsuro Ohmor. Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia. International journal of molecular sciences. vol 18. issue 3. 2017-04-20. PMID:28335437. |
clozapine is an atypical antipsychotic, that is established as the treatment of choice for treatment-resistant schizophrenia (scz). |
2017-04-20 |
2023-08-13 |
Not clear |
| Hong-Qiang Sun, Su-Xia Li, Fang-Bin Chen, Yan Zhang, Peng Li, Mei Jin, Yan Sun, Fan Wang, Wei-Feng Mi, Le Shi, Jing-Li Yue, Fu-De Yang, Lin L. Diurnal neurobiological alterations after exposure to clozapine in first-episode schizophrenia patients. Psychoneuroendocrinology. vol 64. 2017-04-18. PMID:26630391. |
diurnal neurobiological alterations after exposure to clozapine in first-episode schizophrenia patients. |
2017-04-18 |
2023-08-13 |
Not clear |
| Dan-Dan Tian, Wei Wang, Hua-Ning Wang, Stephen Cho Wing Sze, Zhang-Jin Zhan. Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats. Molecules (Basel, Switzerland). vol 21. issue 6. 2017-04-18. PMID:27240333. |
radix rehmanniae, fructus schisandrae, radix bupleuri, and fructus gardeniae are often used alongside with clozapine (clz) for schizophrenia patients in order to reduce side effects and enhance therapeutic efficacy. |
2017-04-18 |
2023-08-13 |
rat |
| Julia E H Brown, Gisela Mezquida, Emilio Fernandez-Ege. Well-being in clozapine-treated schizophrenia patients: The significance of positive symptoms. Comprehensive psychiatry. vol 68. 2017-04-12. PMID:27234195. |
this cross-sectional study sought to explore potential clinical factors that may predict subjective well-being scores in chronic schizophrenia patients (n=142) receiving clozapine treatment. |
2017-04-12 |
2023-08-13 |
Not clear |
| Jari-Pekka Klemettilä, Olli Kampman, Niko Seppälä, Merja Viikki, Mari Hämäläinen, Eeva Moilanen, Esa Leinone. Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine. Nordic journal of psychiatry. vol 71. issue 2. 2017-03-29. PMID:27658459. |
resistin as an inflammatory marker in patients with schizophrenia treated with clozapine. |
2017-03-29 |
2023-08-13 |
Not clear |
| Aysun Kalenderoğlu, Mustafa Çeli. [Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series]. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 27. issue 1. 2017-03-27. PMID:27369686. |
[augmentation of clozapine with paliperidone in schizophrenia patients with partial response to treatment: a case series]. |
2017-03-27 |
2023-08-13 |
Not clear |
| Aysun Kalenderoğlu, Mustafa Çeli. [Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series]. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 27. issue 1. 2017-03-27. PMID:27369686. |
clozapine is the only antipsychotic which has definitely shown to be effective in refractory schizophrenia. |
2017-03-27 |
2023-08-13 |
Not clear |
| Aysun Kalenderoğlu, Mustafa Çeli. [Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series]. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 27. issue 1. 2017-03-27. PMID:27369686. |
clozapine treatment is usually preferred in schizophrenia patients with a partial response to treatment and augmentation strategies are tried when clozapine also fails to provide full treatment response. |
2017-03-27 |
2023-08-13 |
Not clear |
| Aysun Kalenderoğlu, Mustafa Çeli. [Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series]. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 27. issue 1. 2017-03-27. PMID:27369686. |
in this case series treatments of 5 schizophrenia patients who still had symptoms despite clozapine treatment were augmented with paliperidone during 6 months of follow up. |
2017-03-27 |
2023-08-13 |
Not clear |
| Aysun Kalenderoğlu, Mustafa Çeli. [Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series]. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 27. issue 1. 2017-03-27. PMID:27369686. |
evaluation of paliperidone's effects on negative symptoms in schizophrenia patients with partial response to clozapine treatment using randomized, placebo controlled studies may provide an important treatment choice. |
2017-03-27 |
2023-08-13 |
Not clear |
| Jadwiga Piwowarska, Maria Radziwoń-Zaleska, Martyna Dmochowska, Ewa Szepietowska, Halina Matsumoto, Grażyna Sygitowicz, Andrzej Pilc, Jacek Łukaszkiewic. The usefulness of monitored therapy using Clozapine concentration in the blood serum for determining drug dose in Polish schizophrenic patients. Pharmacological reports : PR. vol 68. issue 6. 2017-03-23. PMID:27588387. |
the aim of the study is to evaluate the advisability of systematic monitoring of clozapine (clo) concentration in serum during treatment of schizophrenia in polish psychiatric patients. |
2017-03-23 |
2023-08-13 |
Not clear |
| Petru Ifteni, Andreea S Szalontay, Andreea Teodoresc. Reducing Restraint With Clozapine in Involuntarily Admitted Patients With Schizophrenia. American journal of therapeutics. vol 24. issue 2. 2017-03-14. PMID:27984264. |
reducing restraint with clozapine in involuntarily admitted patients with schizophrenia. |
2017-03-14 |
2023-08-13 |
Not clear |
| Shyam Sundar Arumugham, Jagadisha Thirthalli, Chittaranjan Andrad. Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia. Expert review of clinical pharmacology. vol 9. issue 9. 2017-03-10. PMID:27322602. |
efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia. |
2017-03-10 |
2023-08-13 |
Not clear |
| Shyam Sundar Arumugham, Jagadisha Thirthalli, Chittaranjan Andrad. Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia. Expert review of clinical pharmacology. vol 9. issue 9. 2017-03-10. PMID:27322602. |
a substantial proportion (40-70%) of patients with treatment-resistant schizophrenia experience persistent symptoms despite an adequate clozapine trial. |
2017-03-10 |
2023-08-13 |
Not clear |
| E Trinczek, M Heinzel-Gutenbrunner, M Haberhausen, C J Bachman. Time to Initiation of Clozapine Treatment in Children and Adolescents with Early-Onset Schizophrenia. Pharmacopsychiatry. vol 49. issue 6. 2017-03-09. PMID:27737473. |
time to initiation of clozapine treatment in children and adolescents with early-onset schizophrenia. |
2017-03-09 |
2023-08-13 |
Not clear |
| Masahiko Kawano, Hidehiro Oshibuchi, Takaaki Kawano, Hiroyuki Muraoka, Takahiro Tsutsumi, Makiko Yamada, Ken Inada, Jun Ishigook. Dopamine dynamics during emotional cognitive processing: Implications of the specific actions of clozapine compared with haloperidol. European journal of pharmacology. vol 781. 2017-03-08. PMID:27085900. |
clozapine has improved efficacy relative to typical antipsychotics in schizophrenia treatment, particularly regarding emotional symptoms. |
2017-03-08 |
2023-08-13 |
rat |